LCM
ZVRA icon

Laurion Capital Management’s Zevra Therapeutics ZVRA Stock Holding History

Laurion Capital Management’s Portfolio ZVRA Stock Details ZVRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-31,200
Closed -$150K – 663
2023
Q3 		$150K Buy
+31,200
New +$156K ﹤0.01% 436
2023
Q2 		– Sell
-571,200
Closed -$3.14M – 762
2023
Q1 		$3.14M Hold
571,200
– – 0.14% 257
2022
Q4 		$2.62M Hold
571,200
– – 0.07% 300
2022
Q3 		$3.56M Sell
571,200
-11,061
-2% -$62.6K 0.1% 281
2022
Q2 		$2.6M Buy
+582,261
New +$2.65M 0.11% 209

Other funds holding ZVRA

NCM
Nantahala Capital Management New Canaan, Connecticut $1.6B AUM 121.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Janney Montgomery Scott
Janney Montgomery Scott Philadelphia, Pennsylvania $40.4B AUM 21.2% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
6CM
683 Capital Management New York $1.08B AUM 85.52% 1-Year Est. Return
RPCONE
Retirement Planning Company of New England Warwick, Rhode Island $246M AUM 27.83% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return